[McArdle's disease: therapeutic use of depot-glucagon].
Typical signs and findings of McArdle's disease were noted in a 27-year-old women. Echocardiographically there was impaired myocardial function. Subcutaneous injection of 2 mg depot-glucagon increased blood sugar levels with objective improvement of muscular function. This is suggested as a practical method of treatment for anticipated increase in muscular stress.
D000328:Adult; D004452:Echocardiography; D005260:Female; D005934:Glucagon / Q000627:therapeutic use*; D006008:Glycogen Storage Disease / Q000188:drug therapy*; D006012:Glycogen Storage Disease Type V / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D012646:Self Administration
D005934:Glucagon
McArdle-Erkrankung; therapeutischer Einstaz von Depot-Glucagon.